Clinical Trials Directory

Trials / Completed

CompletedNCT02841397

Validation of Noninvasive Hemoglobin, Comparison of PVI to Standard Methods, and Validation of Clinical Efficacy of ORI

Validation of a Pulse Oximetry Based Hemoglobin Measurement System. Comparison of Plethysmographic Variability Index to Standard Methods of Guiding Fluid and Transfusion Management in the Critically Ill Adult Patients. Validation of Clinical Efficacy of ORI for Supplemental Oxygen Titration

Status
Completed
Phase
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Masimo Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study goal is to establish the correlation of hemoglobin values determined by the noninvasive pulse oximetry-determined hemoglobin (SpHb) system with hemoglobin as measured by other validated devices. The study will also evaluation oxygen reserve index (ORI) to correlate with partial pressure of oxygen (PaO2), and to evaluate pleth variability index (PVI) with stroke volume variation (SVV) or pulse pressure variation (PPV) values.

Conditions

Interventions

TypeNameDescription
DEVICEMasimo Pulse CO-OximeterNoninvasive pulse oximeter with various features for measurement of hemoglobin, pleth variability index, and oxygen reserve index

Timeline

Start date
2017-03-09
Primary completion
2017-10-11
Completion
2017-10-11
First posted
2016-07-22
Last updated
2021-10-21
Results posted
2021-10-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02841397. Inclusion in this directory is not an endorsement.